Peutz-Jeghers syndrome screening: Difference between revisions
Jump to navigation
Jump to search
Hamid Qazi (talk | contribs) No edit summary |
Hamid Qazi (talk | contribs) |
||
| Line 13: | Line 13: | ||
*[[Enteroclysis]] | *[[Enteroclysis]] | ||
*[[Colonoscopy]] | *[[Colonoscopy]] | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:10, 20 December 2017
|
Peutz-Jeghers syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peutz-Jeghers syndrome screening On the Web |
|
American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening |
|
Risk calculators and risk factors for Peutz-Jeghers syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou test (Pap test) is recommended among patients with Peutz-Jeghers syndrome.
Screening
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:[1]
References
- ↑ Syngal, Sapna; Brand, Randall E; Church, James M; Giardiello, Francis M; Hampel, Heather L; Burt, Randall W (2015). "ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes". The American Journal of Gastroenterology. 110 (2): 223–262. doi:10.1038/ajg.2014.435. ISSN 0002-9270.